Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung cancer in the era of targeted therapy: a cytologist's perspective.

Archives of pathology & laboratory medicine - 1 Dec 2013

Zakowski Maureen F

Abstract excerpt

CONTEXT: The diagnosis and treatment of non-small cell lung cancer have changed dramatically in the past few years. The discovery of activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor and the use of drugs that successfully target those mutations are among the key advances that have led to a shift in the practice of oncology and pathology, with perhaps the greatest effect on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Source

Identifiers

PMID: 23597048
DOI: 10.5858/arpa.2013-0029-RA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lung cancer in the era of targeted therapy: a cytologist's perspective.PMID 23597048Read ↗

Respiratory cytology in the era of molecular diagnostics: a review.Semantic proximity Read ↗

[Targeted therapy in lung cancer: molecular testing using cytological specimens].Semantic proximity Read ↗

Molecular diagnostics of lung carcinomas.Semantic proximity Read ↗

Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.Semantic proximity Read ↗

EGFR analysis: current evidence and future directions.Semantic proximity Read ↗

[Molecular diagnostics of lung cancer].Semantic proximity Read ↗

Molecular pathology of non-small cell lung cancer: a practical guide.Semantic proximity Read ↗

[Molecular pathology of pulmonary carcinomas].Semantic proximity Read ↗

The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.Semantic proximity Read ↗

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.Semantic proximity Read ↗

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.Semantic proximity Read ↗

Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.